Form 4 for IRD Opus Genetics, Inc.
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0000905148-26-000904 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | 2026-02-12 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | F - Tax | $3.39 | -5,313 | 520.5K | -1% | -$18.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | F | D | 5,313 | $3.39 | 520,494 | D | — | — |